TY  - GEN
AU  - McCarthy,T
TI  - Development of EMA401 as an orally-administered, highly-selective angiotensin II type 2 receptor antagonist for the treatment of neuropathic pain
SN  - 1529-8027
PY  - 2015///0615
KW  - Administration, Oral
KW  - Angiotensin II Type 2 Receptor Blockers
KW  - administration & dosage
KW  - Benzhydryl Compounds
KW  - Clinical Trials, Phase II as Topic
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Isoquinolines
KW  - Male
KW  - Multicenter Studies as Topic
KW  - Neuralgia, Postherpetic
KW  - drug therapy
KW  - Pain Measurement
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1111/jns.12080_4
ER  -